Search research articles
Contact Us
Filters
Showing results (181-190 of 225) with videos related to
Page
of 23
Sort By:
Thrombosis and Haemostasis
|
July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
Edelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Blood
|
December 24, 2015
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
Ida Martinelli, Anthonie W A Lensing, Saskia Middeldorp, et al.
Thrombosis Research
|
June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses
Suzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 17, 2021
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study
Anthony Maraveyas, Noémie Kraaijpoel, George Bozas, et al.
Chest
|
September 12, 2018
Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population
Philip S Wells, Martin H Prins, Jan Beyer-Westendorf, et al.
Chest
|
June 6, 2016
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension
Philip S Wells, Martin H Prins, Bennett Levitan, et al.
Thrombosis Research
|
November 26, 2016
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials
Jan Beyer-Westendorf, Anthonie W A Lensing, Roopen Arya, et al.
Journal of Personalized Medicine
|
August 26, 2022
Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational Trial
Tom A Schröder, Henry Leonhardt, Dominik Haim, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
The Lancet. Haematology
|
April 1, 2016
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Martin H Prins, Anthonie W A Lensing, Tim A Brighton, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 225) with videos related to
Sort By:
Page
of 23
Thrombosis and Haemostasis
|
July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
Edelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Blood
|
December 24, 2015
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
Ida Martinelli, Anthonie W A Lensing, Saskia Middeldorp, et al.
Thrombosis Research
|
June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses
Suzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 17, 2021
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study
Anthony Maraveyas, Noémie Kraaijpoel, George Bozas, et al.
Chest
|
September 12, 2018
Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population
Philip S Wells, Martin H Prins, Jan Beyer-Westendorf, et al.
Chest
|
June 6, 2016
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension
Philip S Wells, Martin H Prins, Bennett Levitan, et al.
Thrombosis Research
|
November 26, 2016
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials
Jan Beyer-Westendorf, Anthonie W A Lensing, Roopen Arya, et al.
Journal of Personalized Medicine
|
August 26, 2022
Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational Trial
Tom A Schröder, Henry Leonhardt, Dominik Haim, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
The Lancet. Haematology
|
April 1, 2016
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Martin H Prins, Anthonie W A Lensing, Tim A Brighton, et al.
Page
of 23